Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongchang Zhang

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
Heliyon|December 11, 2023
Presence of MET exon 14 skipping and fusion as mechanism of osimertinb resistance in a lung adenocarcinoma with an EGFR exon 19 deletion that responds to combination of capmatinib and osimertinb: A case reportSiqi Xiang, Liang Zeng, Mingjun Xiang, et al.
Thoracic Cancer|February 22, 2019
Tyrosine kinase inhibitor acquired resistance mechanism alternates between EGFR and ALK in a lung adenocarcinoma patientYijuan Hu, Lili Xiao, Nong Yang, et al.
Current Opinion in Oncology|September 9, 2024
Perioperative immunotherapy in nonsmall cell lung cancerRenzhi Zhang, Chun Zou, Liang Zeng, et al.
Protein & Cell|October 15, 2014
A new glimpse of FadR-DNA crosstalk revealed by deep dissection of the E. coli FadR regulatory proteinYongchang Zhang, Rongsui Gao, Huiyan Ye, et al.
International Journal of Environmental Research and Public Health|January 8, 2023
Multi-Risk Assessment of Mine Lithium Battery Fire Based on Quantitative Factor CharacterizationKuikui Li, Yanming Wang, Yongchang Zhang, et al.
Research (Washington, D.C.)|November 15, 2021
A Bioinspired Soft Robot Combining the Growth Adaptability of Vine Plants with a Coordinated Control SystemPengchun Li, Yongchang Zhang, Guangyu Zhang, et al.
Biotechnology Letters|November 13, 2010
Cloning and analysis of the xylAB operon and characterization of xylose isomerase from Thermoanaerobacter ethanolicusLijuan Fan, Yongchang Zhang, Wei Qu, et al.
Translational Lung Cancer Research|March 25, 2020
Rechallenge with erlotinib in osimertinib-resistant lung adenocarcinoma mediated by driver gene loss: a case reportLingli Liu, Analyn Lizaso, Xinru Mao, et al.
Annals of Translational Medicine|November 4, 2020
Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib: a case reportYuling Zhou, Analyn Lizaso, Xinru Mao, et al.
Annals of Translational Medicine|May 2, 2020
PIM1 inhibitor synergizes the anti-tumor effect of osimertinib via STAT3 dephosphorylation in EGFR-mutant non-small cell lung cancerZiyi Sun, Liang Zeng, Miaomiao Zhang, et al.
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
Heliyon|December 11, 2023
Presence of MET exon 14 skipping and fusion as mechanism of osimertinb resistance in a lung adenocarcinoma with an EGFR exon 19 deletion that responds to combination of capmatinib and osimertinb: A case reportSiqi Xiang, Liang Zeng, Mingjun Xiang, et al.
Thoracic Cancer|February 22, 2019
Tyrosine kinase inhibitor acquired resistance mechanism alternates between EGFR and ALK in a lung adenocarcinoma patientYijuan Hu, Lili Xiao, Nong Yang, et al.
Current Opinion in Oncology|September 9, 2024
Perioperative immunotherapy in nonsmall cell lung cancerRenzhi Zhang, Chun Zou, Liang Zeng, et al.
Protein & Cell|October 15, 2014
A new glimpse of FadR-DNA crosstalk revealed by deep dissection of the E. coli FadR regulatory proteinYongchang Zhang, Rongsui Gao, Huiyan Ye, et al.
International Journal of Environmental Research and Public Health|January 8, 2023
Multi-Risk Assessment of Mine Lithium Battery Fire Based on Quantitative Factor CharacterizationKuikui Li, Yanming Wang, Yongchang Zhang, et al.
Research (Washington, D.C.)|November 15, 2021
A Bioinspired Soft Robot Combining the Growth Adaptability of Vine Plants with a Coordinated Control SystemPengchun Li, Yongchang Zhang, Guangyu Zhang, et al.
Biotechnology Letters|November 13, 2010
Cloning and analysis of the xylAB operon and characterization of xylose isomerase from Thermoanaerobacter ethanolicusLijuan Fan, Yongchang Zhang, Wei Qu, et al.
Translational Lung Cancer Research|March 25, 2020
Rechallenge with erlotinib in osimertinib-resistant lung adenocarcinoma mediated by driver gene loss: a case reportLingli Liu, Analyn Lizaso, Xinru Mao, et al.
Annals of Translational Medicine|November 4, 2020
Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib: a case reportYuling Zhou, Analyn Lizaso, Xinru Mao, et al.
Annals of Translational Medicine|May 2, 2020
PIM1 inhibitor synergizes the anti-tumor effect of osimertinib via STAT3 dephosphorylation in EGFR-mutant non-small cell lung cancerZiyi Sun, Liang Zeng, Miaomiao Zhang, et al.
Pageof 17